Total Funding
79
62
Total FundingConvertible Note raised
Growth Score
-11 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26965
NovaScan develops and commercializes technology for cancer detection.
Craig Davis: CEOPast Role: HealthiosXchange, Associate Partner- William Gregory: Founder
About the Company
NovaScan provides diagnostic products that apply bioelectrical impedance to assess tissue characteristics relevant to cancer detection. Its MarginScan device performs ex vivo and in vivo margin evaluation by generating immediate electrical measurements during clinical procedures. The nsCanary tool examines biopsy cores directly after sampling to
indicate whether malignant tissue is present. NovaScan also uses machine-learning models to interpret impedance signatures and distinguish cancerous from non-cancerous tissue. These products are designed to support clinical decision-making through rapid, instrument-based analysis.
